CAS 161796-78-7
:Esomeprazol sódico
Descrição:
Esomeprazol sódico é um inibidor da bomba de prótons (IBP) utilizado principalmente para tratar a doença do refluxo gastroesofágico (DRGE) e outras condições associadas à produção excessiva de ácido estomacal. É o S-enantiômero do omeprazol, que melhora sua eficácia e biodisponibilidade. Este composto é tipicamente apresentado como um sal de sódio, o que melhora sua solubilidade em soluções aquosas. Esomeprazol sódico atua inibindo irreversivelmente a enzima H+/K+ ATPase nas células parietais gástricas, levando a uma redução significativa na secreção de ácido gástrico. É caracterizado por sua forma de pó cristalino branco a off-white, com uma fórmula molecular que inclui carbono, hidrogênio, nitrogênio, oxigênio e sódio. A substância é geralmente estável em condições normais, mas deve ser armazenada longe da umidade e da luz para manter sua potência. Comumente administrado por via oral, Esomeprazol sódico é bem absorvido no trato gastrointestinal, com concentrações plasmáticas máximas ocorrendo dentro de algumas horas após a administração. Sua farmacocinética pode ser influenciada por fatores como a ingestão de alimentos e variações metabólicas individuais.
Fórmula:C17H19N3O3S·Na
InChI:InChI=1S/C17H19N3O3S.Na/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17;/h5-8H,9H2,1-4H3,(H,19,20);/t24-;/m0./s1
Chave InChI:InChIKey=HVAJOLFRLWQQQL-JIDHJSLPSA-N
SMILES:S(CC1=C(C)C(OC)=C(C)C=N1)(=O)C=2NC=3C(N2)=CC=C(OC)C3.[Na]
Sinónimos:- (S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole sodium salt
- (S)-Omeprazole sodium
- 1H-Benzimidazole, 5-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, sodium salt
- 1H-Benzimidazole, 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, sodium salt, (S)-
- 1H-Benzimidazole, 6-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, sodium salt (1:1)
- 1H-benzimidazole, 5-Methoxy-2-[[(4-Methoxy-3,5-dimethyl-2-PYRIDINYL)methyl]sulfinyl]-, sodium salt
- 5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl-1H-benzimidazole sodium salt
- Bis[5-Methoxy-2-[(4-Methoxy-3,5-Dimethyl-2-Pyridyl)Methylsulfinyl]Benzimidazol-1-Yl]Magnesium
- Esomeprazole Na
- Esomeprazole sodium salt
- Esomeprazoleandsalts
- H 199/18 sodium
- Sodium 5-Methoxy-2-{[(4-Methoxy-3,5-Dimethylpyridin-2-Yl)Methyl]Sulfinyl}Benzimidazol-1-Ide
- sodium 5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-2,3-dihydrobenzimidazol-1-ide
- Ver mais sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
14 produtos.
Esomeprazole Sodium
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H18N3NaO3SCor e Forma:White Off-White PowderPeso molecular:367.096661H-Benzimidazole, 6-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, sodium salt (1:1)
CAS:Fórmula:C17H18N3NaO3SPureza:%Cor e Forma:SolidPeso molecular:367.3979Esomeprazole sodium salt hydrate
CAS:Fórmula:C17H18N3NaO3SPureza:(Titration) ≥ 98.0%Cor e Forma:White to off-white or pale yellow crystalline powderPeso molecular:367.40Esomeprazole Sodium Salt
CAS:Fórmula:C17H18N3O3S·NaCor e Forma:White To Off-White SolidPeso molecular:344.42 22.99(S)-Omeprazole Sodium Salt
CAS:Fórmula:C17H18N3NaO3SPureza:>98.0%(T)(HPLC)Cor e Forma:White to Light yellow powder to crystalPeso molecular:367.40Esomeprazole Sodium
CAS:Esomeprazole Sodium ((S)-Omeprazole sodium) is the S-isomer of omeprazole with selective and irreversible proton pump inhibitor activity.Fórmula:C17H18N3O3S·NaPureza:98.17% - >99.99%Cor e Forma:SolidPeso molecular:367.4Sodium (S)-6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide
CAS:Pureza:95.0%Peso molecular:367.3999938964844Esomeprazole sodium
CAS:<p>Esomeprazole is a proton pump inhibitor used to treat gastroesophageal reflux disease and other conditions where there is too much stomach acid. It is available as a capsule or tablet in doses of 20, 40, and 60 mg. Esomeprazole inhibits the production of gastric acid by blocking the hydrogen/potassium adenosine triphosphate (H+/K+ ATPase) enzyme system at the secretory surface of the gastric parietal cells. Omeprazole is an acidic drug that blocks the H+/K+ ATPase enzyme system. The two drugs have been compared in two-way crossover studies using healthy volunteers who were given omeprazole magnesium for one week followed by esomeprazole sodium for another week. There was no difference in their effect on acid secretion or on heartburn relief. The plasma concentrations of both drugs increased with increasing dose, but there was no significant difference between them in terms of either</p>Fórmula:C17H18N3NaO3SPureza:(%) Min. 95%Cor e Forma:PowderPeso molecular:367.4 g/molEsomeprazole sodium - EP
CAS:<p>Esomeprazole sodium is a proton pump inhibitor that decreases the production of stomach acid. It is used in the treatment of symptoms such as heartburn, regurgitation, and ulcers caused by gastroesophageal reflux disease (GERD). Esomeprazole sodium has been shown to reduce the amount of acid produced in the stomach and to increase the pH level in the stomach. This drug also has significant interactions with other drugs, which can lead to an increased risk of adverse events. Esomeprazole sodium is excreted from the body through urine and feces. The active form of esomeprazole is also found in wastewater treatment plants and can contribute to antimicrobial resistance.</p>Fórmula:C17H18N3NaO3SPureza:Min. 95%Cor e Forma:White/Off-White SolidPeso molecular:367.4 g/mol













